Evidence map›Paper›PMID 25655876›Full record

Trial reportAJNR. American journal of neuroradiology2015

WEB Treatment of Intracranial Aneurysms: Feasibility, Complications, and 1-Month Safety Results with the WEB DL and WEB SL/SLS in the French Observatory.

L Pierot, J Moret, F Turjman, D Herbreteau, H Raoult, X Barreau, S Velasco, H Desal, A-C Januel, P Courtheoux and 5 more

Open access · bronzeAbstract readClinical TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in AJNR. American journal of neuroradiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 5 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 5 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Endoluminal flow diverters in the treatment of sidewall and bifurcation aneurysm: A systematic review and meta-analysis of complications and angiographic outcomes.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2022
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 2 countries.

L PierotFrom the Department of Neuroradiology (L.P., S.S.), Hôpital Maison-Blanche, Université Reims-Champagne-Ardenne, Reims, France lpierot@gmail.com.
J MoretDepartment of Neuroradiology (J.M., L.S.), Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France.
F TurjmanDepartment of Neuroradiology (F.T.), Centre Hospitalier Universitaire Lyon, Lyon, France.
D HerbreteauDepartment of Neuroradiology (D.H.), Centre Hospitalier Universitaire Tour, Tours, France.
H RaoultDepartment of Neuroradiology (H.R., J.-Y.G.), Centre Hospitalier Universitaire Rennes, Rennes, France.
X BarreauDepartment of Neuroradiology (X.B.), Centre Hospitalier Universitaire Bordeaux, Bordeaux, France.
S VelascoDepartment of Neuroradiology (S.V.), Centre Hospitalier Universitaire Poitiers, Poitiers, France.
H DesalDepartment of Neuroradiology (H.D.), Centre Hospitalier Universitaire Nantes, Nantes, France.
A-C JanuelDepartment of Neuroradiology (A.-C.J., C.C.), Centre Hospitalier Universitaire Toulouse, Toulouse, France.
P CourtheouxDepartment of Neuroradiology (P.C.), Centre Hospitalier Universitaire Caen, Caen, France.
J-Y GauvritDepartment of Neuroradiology (H.R., J.-Y.G.), Centre Hospitalier Universitaire Rennes, Rennes, France.
C CognardDepartment of Neuroradiology (A.-C.J., C.C.), Centre Hospitalier Universitaire Toulouse, Toulouse, France.
S SoizeFrom the Department of Neuroradiology (L.P., S.S.), Hôpital Maison-Blanche, Université Reims-Champagne-Ardenne, Reims, France.
A MolyneuxDepartment of Neuroradiology (A.M.), Oxford Neurovascular and Neuroradiology Research Unit, Oxford Radcliffe Hospital, Oxford, United Kingdom.
L SpelleDepartment of Neuroradiology (J.M., L.S.), Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France.
Université de Reims Champagne-Ardenne · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Caen Normandie · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Toulouse · FRFondation Ophtalmologique Adolphe de Rothschild · FRHôpital Paule de Viguier · FRHôpital Pontchaillou · FRInstitut de Recherche en Informatique et Systèmes Aléatoires · FRMécanismes Adaptatifs et Evolution · FRScience and Technology Corporation for Naval, Maritime and Riverine Industry Development · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeSafety analyses in the French Observatory have shown that treatment of intracranial aneurysms by using flow disruption with the Woven EndoBridge Device (WEB) is safe, with low morbidity and no mortality. The objective of this study was to analyze treatment feasibility, complications, and safety results in patients treated with the Woven EndoBridge Device Dual-Layer (WEB DL) and Woven EndoBridge Device Single-Layer/Single-Layer Sphere (WEB SL/SLS) in the French Observatory. MATERIALS AND

methodsPatients with bifurcation aneurysms were included in this prospective, multicenter good clinical practices study. A medical monitor independently analyzed procedural and clinical data. The study started with the WEB DL, and secondarily, the WEB SL/SLS was authorized in the study.

resultsBetween November 2012 and January 2014, 10 French centers included 62 patients with 63 aneurysms. Thirty patients with 31 aneurysms were treated with the WEB DL, and 32 patients with 32 aneurysms, with the WEB SL/SLS. The percentage of anterior communicating artery aneurysms treated with WEB SL/SLS was significantly higher (37.5%) compared with WEB DL (12.9%) (P = .04). The WEB SL/SLS was more frequently used in aneurysms of <10 mm than the WEB DL (respectively, 96.9% and 67.7%; P = .002). Morbidity was similar in both groups (WEB DL, 3.3%; WEB SL/SLS, 3.1%), and mortality was 0.0% in both groups.

conclusionsThis comparative study shows increased use of WEB treatment in ruptured, small, and anterior communicating artery aneurysms when using WEB SL/SLS. There was a trend toward fewer thromboembolic complications with the WEB SL/SLS. With both the WEB DL and WEB SL/SLS, the treatment was safe, with low morbidity and no mortality.

Indexed as

AdolescentAdultAgedEmbolization, TherapeuticEquipment SafetyFeasibility StudiesFemaleHumansIntracranial AneurysmMaleMiddle AgedPostoperative ComplicationsProspective StudiesTreatment Outcome

Identifiers

PMID25655876
PMCPMC7990613
OpenAlexW2045682018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.